Breaking News Instant updates and real-time market news.

OBSV

ObsEva

$17.21

2.68 (18.44%)

07:48
06/19/18
06/19
07:48
06/19/18
07:48

ObsEva price target raised to $31 from $23 at BMO Capital

BMO Capital analyst Peter Lawson raised his price target on ObsEva to $31 following the positive OBE2109 EDELWEISS data in endometriosis, saying the results "confirm comparable high dose efficacy to leader Elagolix" with better balanced pain benefit. Lawson adds that the 5-month bone data expected in Q4 of this year will further support the OBE2109 preferable profile, leading to the initiation of a Phase 3 endometriosis study in Q1 of 2019. The analyst is also positive on additional upside coming from the Nolasiban live birth rate data and OBE022 phase 2 read-out in Q4, keeping his Outperform rating on ObsEva.

  • 20

    Jun

OBSV ObsEva
$17.21

2.68 (18.44%)

06/18/18
BMOC
06/18/18
NO CHANGE
Target $31
BMOC
Outperform
ObsEva positive EDELWEISS data de-risks Phase 3 studies, says BMO Capital
BMO Capital analyst Do Kim raised the price target for ObsEva to $31 from $23, while reiterating an Outperform rating on the shares, following positive OBE2109 EDELWEISS data in endometriosis. He believes the data confirms OBE2109 benefit and further de-risks Phase 3 studies in uterine fibroid. The analyst also raised his probability of success to 70% and said he expects 6-month bone data in Q4 to further support OBE2109 preferable profile, and initiation of Phase 3 endometriosis study in Q1. In the interim, additional upside could come from Nolasiban live birth rate data and OBE022 Phase 2 data in Q4.
06/18/18
BMOC
06/18/18
NO CHANGE
Target $31
BMOC
Outperform
ObsEva price target raised to $31 from $23 at BMO Capital
BMO Capital analyst Do Kim raised the price target on ObsEva to $31 from $23 after the company reported 12-week results from its Phase 2b clinical trial of linzagolix for the treatment of endometriosis-associated pain. Kim maintains an Outperform rating on ObsEva shares.
06/12/18
BMOC
06/12/18
INITIATION
Target $23
BMOC
Outperform
ObsEva initiated with an Outperform at BMO Capital
BMO Capital analyst Do Kim initiated ObsEva with an Outperform rating and a price target of $23, saying the company's OBE2109 offers "the best drug profile among GnRH antagonists" which will allow it to capture a "meaningful market share in uterine fibrosis and endometriosis". The analyst adds that ObsEva's Nolasiban is underappreciated despite the positive Phase 3 data, and the live birth results in Q4 may lead to investors' reassessment of the treatment.
02/28/18
HCWC
02/28/18
NO CHANGE
Target $27
HCWC
Buy
ObsEva target raised to $27 on positive nolasiban data at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju raised his price target for ObsEva to $27 citing the positive top-line data from the first pivotal Phase 3 trial of its most advanced clinical-stage candidate, nolasiban. The analyst views the results as statistically significant and clinically meaningful. He reiterates a Buy rating on ObsEva.

TODAY'S FREE FLY STORIES

SBUX

Starbucks

$66.51

0.41 (0.62%)

14:41
12/13/18
12/13
14:41
12/13/18
14:41
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks says goal to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

GPX

GP Strategies

$13.13

0.06 (0.46%)

14:41
12/13/18
12/13
14:41
12/13/18
14:41
Conference/Events
GP Strategies management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 18

    Dec

TSLA

Tesla

$371.33

4.57 (1.25%)

, GOOG

Alphabet

$1,057.32

-6.24 (-0.59%)

14:41
12/13/18
12/13
14:41
12/13/18
14:41
Periodicals
Tesla's Vaish resigns to start company at Google's Area120, CNBC says »

Parag Vaish, head of…

TSLA

Tesla

$371.33

4.57 (1.25%)

GOOG

Alphabet

$1,057.32

-6.24 (-0.59%)

GOOGL

Alphabet Class A

$1,068.33

-5.33 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 03

    Mar

GPX

GP Strategies

$13.13

0.06 (0.46%)

14:40
12/13/18
12/13
14:40
12/13/18
14:40
Conference/Events
GP Strategies management to meet with Barrington »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 18

    Dec

HIIQ

Health Insurance Innovations

$36.84

6.775 (22.53%)

14:40
12/13/18
12/13
14:40
12/13/18
14:40
Recommendations
Health Insurance Innovations analyst commentary  »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SPY

SPDR S&P 500 ETF Trust

$264.50

-1.03 (-0.39%)

, SPX

S&P 500

$0.00

(0.00%)

14:36
12/13/18
12/13
14:36
12/13/18
14:36
General news
NYPD says monitoring multiple bomb threats, not considered credible »

The official Twitter of…

SPY

SPDR S&P 500 ETF Trust

$264.50

-1.03 (-0.39%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:35
12/13/18
12/13
14:35
12/13/18
14:35
General news
Saudi PIF has been a swing buyer of stocks »

Saudi PIF has been a…

SBUX

Starbucks

$66.43

0.33 (0.50%)

14:32
12/13/18
12/13
14:32
12/13/18
14:32
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks to expand nitro…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

SBUX

Starbucks

$66.41

0.31 (0.47%)

14:31
12/13/18
12/13
14:31
12/13/18
14:31
Hot Stocks
Starbucks bringing delivery to 25% of company-owned U.S. stores by Q2 2019 »

Starbucks is expanding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

CSCO

Cisco

$47.28

-0.15 (-0.32%)

14:30
12/13/18
12/13
14:30
12/13/18
14:30
Conference/Events
UBS to host a conference call with Cisco »

UBS IT Hardware Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 04

    Mar

SBUX

Starbucks

$66.35

0.25 (0.38%)

14:28
12/13/18
12/13
14:28
12/13/18
14:28
Hot Stocks
Starbucks says mix of mobile order and drive-through rising »

Starbucks sees more…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

14:25
12/13/18
12/13
14:25
12/13/18
14:25
General news
Treasury reported a -$204.9 budget deficit »

Treasury reported a…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
12/13/18
12/13
14:17
12/13/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
12/13/18
12/13
14:16
12/13/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJT

DJ Transportation Average

$0.00

(0.00%)

, DAL

Delta Air Lines

$53.65

-2.62 (-4.66%)

14:15
12/13/18
12/13
14:15
12/13/18
14:15
Hot Stocks
Transportation index hits lowest level in about twelve months »

Shares of transportation…

$DJT

DJ Transportation Average

$0.00

(0.00%)

DAL

Delta Air Lines

$53.65

-2.62 (-4.66%)

MATX

Matson

$34.97

-1.7 (-4.64%)

LSTR

Landstar System

$94.43

-2.18 (-2.26%)

KSU

Kansas City Southern

$96.85

-0.74 (-0.76%)

CSX

CSX

$68.22

-0.65 (-0.94%)

CHRW

C.H. Robinson

$84.60

-3.49 (-3.96%)

EXPD

Expeditors

$70.50

-1.75 (-2.42%)

XPO

XPO Logistics

$47.15

-13.1 (-21.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

AWK

American Water

$97.50

0.37 (0.38%)

14:14
12/13/18
12/13
14:14
12/13/18
14:14
Hot Stocks
American Water says CPUC approves general rate case »

The California Public…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWL

Newell Brands

$22.75

-0.81 (-3.44%)

14:10
12/13/18
12/13
14:10
12/13/18
14:10
Options
Newell Brands calls lead puts 15:1 as shares drop 3.5% »

Newell Brands calls lead…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:05
12/13/18
12/13
14:05
12/13/18
14:05
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

14:01
12/13/18
12/13
14:01
12/13/18
14:01
General news
Treasury Budget data reported »

November Treasury Budget…

DFFN

Diffusion Pharmaceuticals

$0.23

0.0176 (8.32%)

14:01
12/13/18
12/13
14:01
12/13/18
14:01
Hot Stocks
Diffusion Pharmaceuticals announces 1-for-15 reverse stock split »

Diffusion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QSR

Restaurant Brands

$54.38

0.35 (0.65%)

14:00
12/13/18
12/13
14:00
12/13/18
14:00
Options
Notable call activity in Restaurant Brands as bullish position is adjusted »

Notable call activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LVS

Las Vegas Sands

$55.27

-0.19 (-0.34%)

, WYNN

Wynn Resorts

$108.68

-0.79 (-0.72%)

13:59
12/13/18
12/13
13:59
12/13/18
13:59
Periodicals
Chanos shorting Wynn Resorts, Las Vegas Sands amid trade war, CNBC reports »

Short-seller Jim Chanos…

LVS

Las Vegas Sands

$55.27

-0.19 (-0.34%)

WYNN

Wynn Resorts

$108.68

-0.79 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$66.80

0.7 (1.06%)

13:56
12/13/18
12/13
13:56
12/13/18
13:56
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks sees growing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

SBUX

Starbucks

$66.81

0.71 (1.07%)

13:56
12/13/18
12/13
13:56
12/13/18
13:56
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks sees U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

13:55
12/13/18
12/13
13:55
12/13/18
13:55
General news
U.S. equities remain mixed after rotating lower »

U.S. equities remain…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.